Sushma Iyengar
About Sushma Iyengar
Sushma Iyengar is the Associate Director of Global Regulatory Sciences, Precision Medicine at Bristol-Myers Squibb, with extensive experience in oncology diagnostics and regulatory affairs.
Current Role at Bristol-Myers Squibb
Sushma Iyengar currently serves as the Associate Director of Global Regulatory Sciences, Precision Medicine at Bristol-Myers Squibb, based in Princeton, NJ. In this role, she contributes to global regulatory strategies for precision medicine, leveraging her extensive background in oncology diagnostics.
Previous Experience at Merck
Prior to her current position, Sushma Iyengar worked at Merck as an Associate Director in Global Medical Affairs, focusing on oncology biomarkers and companion diagnostics. She held this role from 2017 to 2019 while based in Kenilworth, New Jersey, where she contributed to the medical affairs strategy and execution.
Professional Journey in Clinical Affairs and Medical Writing
Sushma Iyengar's professional journey includes roles at various esteemed organizations. She was a Clinical Affairs Scientist for Companion Diagnostics at Agilent Technologies in 2017. Before that, she worked as a Senior Medical Writer at Natera from 2015 to 2016, and as a Science Writer/Editor at Cactus Communications from 2013 to 2015. Earlier in her career, she served as a Post-Doctoral Research Associate at the University of Southern California from 2011 to 2013.
Educational Background in Life Sciences
Sushma Iyengar's educational credentials include a PhD in Cancer Genetics from the University of California, Davis, obtained between 2005 and 2011. She also holds a Master's degree in Biomedical Genetics from the University of Madras (2003-2005) and a Bachelor's degree in Zoology from Stella Maris College (2000-2003). Additionally, she completed a certificate program in Regulatory Affairs for Medical Devices and Pharmaceuticals from the Regulatory Affairs Professionals Society between 2014 and 2015.
Expertise in Oncology and Precision Medicine
Sushma Iyengar has a robust background in oncology diagnostics and precision medicine, particularly within regulatory sciences. Her career has been marked by a focus on oncology biomarkers and companion diagnostics, underlining her expertise and commitment to advancing medical sciences in these fields.